Video

The future of drug discovery through collaboration with Sanj Kumar

How is collaboration shaping the future of drug discovery, and how can the life sciences community support the next generation of researchers?
Brought to you byDrug Discovery News
| 1 min read
A promotional graphic featuring Sanj Kumar against a blue background, with the title “The Future of Drug Discovery Through Collaboration.”


At ELRIG’s Drug Discovery 2026, the Drug Discovery News team spoke with Sanj Kumar, Chief Executive Officer at ELRIG, about the evolving drug discovery landscape and the importance of collaboration in driving innovation. As the boundaries between academia, biotechnology, and pharmaceutical research continue to become more open, partnerships across these sectors are creating opportunities to advance promising targets and explore a wider range of therapeutic approaches.

In this interview, Kumar discusses how ELRIG brings the drug discovery community together, supports researchers through mentorship and early-career development initiatives, and fosters connections that can lead to new ideas and collaborations. He also reflects on the challenges facing life sciences professionals amid industry restructuring, the growing role of diverse therapeutic modalities beyond small molecules, and the technologies needed to address unmet medical needs and advance future drug discovery efforts.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D molecular visualization of a protein structure, rendered in a ribbon diagram style.
A comparative structural analysis of MC4R complexes reveals how agonist binding influences receptor conformation, ligand interactions, and complex stability.
Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.